Perfect Storm

One of the most delightful things in bioinformatics is the possibility of working with people with really different mindsets. Surely CS geeks are amazing, and everyday I feel that my original background is really a comparative advantage, but, from where I look, nothing beats being in an environment with scientific and cultural diversity. But, lets talk some geekiness now:

A couple of years ago, I did a population genetics simulator in Caml. It was really flexible, allowing for many demographic and genomic scenarios, mating rules, selection… really flexible. I never got to try to publish it because there are many good simulators around (I suggest simuPOP, if you are looking for one) and it would take some time to make it robust and documented for public exposure. But, the interesting part is, when I went to my MSc supervisor (an “old-type” biologist) and after a very exuberant explanation on how flexible the simulator was, he added only one comment: That is all very well and good, but you did not show me the easy to use graphical interface!

Fast forward a couple of years… With regards to a DSL to model drug resistance in the context of infectious diseases that I am developing, I went to my PhD advisor (a population geneticist, malarialogist, biostatistician who knows how to program in C), showed him my rough prototype and he said: People will be able to read this, but, to interact they will want an easy to use graphical user interface. To be honest, this time, I was expecting the comment (I am living in the middle of experimentalists long enough to have learned something). I have no expectations, for my DSL, that domain specialists will write it (well, maybe a couple of them will, if things pick up). If I end up giving my system away to domain specialists, it will have to have a easy to use interface, there is no escaping from that.

Well, DSLs (at least in Scala and in Ruby) have an underlying OO model. Which, most of the times is neither complex nor big. I am starting to suspect that it won’t be too difficult to automatically generate an easy to use interface to input in a “nice” way what could be rendered as DSL programs (or object instances and relationships, if you prefer to look at it that way). For embedded DSLs, which have the whole expressive power of the host language available, that would be unfeasible to do completely. But, at least part of it could be automated. Obviously this idea is not new at all, this is just a rehash of what Lift or Rails do for databases.

I am aware that graphical programming languages never went too far (I actually dislike them), but the scope and context here are completely different, different premises apply. This might be one way of lowering the barrier to rigorous modeling to a wider crowd.

I would like to make a preemptive defensive comment on the new population genetics module.

I am, for now, the sole author of the code that is there (although, in future versions there will be at least code from another person. By the way, if YOU want to participate, your 100% welcome). Although the code is mine there was a lot of help from Peter Cock, one of Biopython’s core developers. Without him, this initial groundwork would not have been possible.

Now for the preemptive defense :

If you look at the module, it has very little functionality included. This is a very deliberate strategy to start small and grow slowly. I am expecting for some feedback (which will be very little, I am sure). I want to grow in small steps, including as much feedback as possible. Test code and documentation have to exist before releasing anything to the public.

In the pipeline there is code for coalescent simulation, statistics (including code supplied by Ralph Haygood, that I am joining with my own) and HapMap. If you are interested in early access to any of this code, please give me a shout as most of it already exists. Alpha testers are more than welcome .

I am currently trying to model antimalarial drug behavior in order to understand the spread of drug resistant malaria. Generally speaking, malaria strains are more or less tolerant to a drug depending on the quantity of drug that is necessary to kill an infection. In theory, a totally resistant infection will survive any treatment, a totally susceptible one will only require small levels of drug to be cleaned.

I see the word drug used in two different ways (for the readers of this blog that are specialists, in some form, on issues regarding drugs, particularly pharmacokinetics, if you see any thing particularly wrong, please do inform me): For instance, SP (Fansidar) is a drug, composed of two drugs (Sulfadoxine and Pyrimethamine). I will use drug for SP and compound for S and P (as active compound seems to be used).

Antimalarial drugs work mainly in the blood stream against asexual parasite forms.

In the blood, compounds have a certain concentration. With time, the body gets rid of compounds (thus the concentration of a compound goes down with time). The concentration of compounds is normally (but not always) modeled using an exponential decay function, being the fundamental parameter the half-life, i.e, the time that it takes for the concentration of a compound to drop to half.

Two other important concepts for drugs that are not taken intravenously (like cheap antimalarials which are oral), are

1. Bioavailability, i.e. the fraction of the compound that actually reaches the circulation. It seems that one of the problems with counterfeit drugs is low bioavailability. Bioavailability is normally discussed in terms of AUC (Area Under the Curve. Being the curve related to the plot of drug concentration against time). I will model it in terms of maximum concentration, half-life and the time it takes to reach maximum concentration in the blood, which by the way is the next concept…
2. The time it takes to reach maximum concentration in the blood, i.e. the time from ingestion to circulation in the blood at maximum concentration. I suppose this time frame has a technical name, but I don’t know it (if you know, drop me an email our comment, please).

Now, back to computational modeling:

A big objective is declarative programming. Preferably a program that can be read by domain specialists (biologists, MDs, biostatisticians, …), with that in mind…

Currently, a computer program in Scala to model drugs look like this.

Compound create "Sulfadoxine"
Compound abbreviation "S"
Compound half_life 116 //hours
Compound bio_availability 408 //1mg to nanoM
val Sulfadoxine = Compound prepare
 
Compound create "Pyrimethamine"
Compound abbreviation "P"
Compound half_life 83 //hours
Compound bio_availability 34 //1mg to nanoM
val Pyrimethamine = Compound prepare
 
Drug create "SP"
Drug includes Sulfadoxine quantity 500
Drug includes Pyrimethamine quantity 25
val SP = Drug prepare

Discussion:

• I am using the “object companion” pattern a lot. The idea is that all “stateful” mess is stored “prepared” in the object (which is the DSL source). When the prepare method is invoked in the object a class (with only immutable vals, very lovely for those of you who are functional programming enthusiasts) is created.
• Notice the dependence on operator precedence on Drug includes quantity (there is not really one, strictly speaking, but assume there is). I would really like to have, per class the ability to define operator precedence, other than not based on dictionary order (à la Prolog).
• I don’t like the val SP = Drug prepare. It is too verbose and too geeky. I would prefer just Drug prepare. I believe that this is possible in Scala as at least at the interpreter level (as the Scala interpreter does it), but I still don’t know how. The idea would be that a val named SP would be added to the local scope in some way. For those computer inclined readers that think that I am being too pedantic and nit-picking, I just have one thing too say: I am really trying to make the system the most pleasant possible to non programmer types, and I think my proposal does not sacrifice elegance and generality (although I would recognize the non-explicit name creation is “strange” – but, hey, the Scala interpreter already does it!)

Caveat emptor, big one: Although drugs (compounds) are discussed in terms of half-lives, bioavailability, etc… these properties are actually not of the drug but of the interaction between the drug and the individual. Making them drug properties only is a “cognitive abuse”, although it has its uses. For instance, my advisor, after looking at the language, was talking about bioavailability for counterfeit drugs, for children between 2 and 5 years. A great example that they are not properties only of the drugs but also, at least, of individuals (and not only that, for instance many drugs are more bioavailable if there are taken in conjunction with, say, fatty foods).

A proper, precise, computational modeling of drugs would be a gigantic undertaking. I have a different approach: Modeling as close as possible to the average domain discourse and hook, in some way, the necessary precision, should the need arise. It is worth noting that “incorrect”, “imprecise” modeling is enough for many tasks.